Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Nutr Cancer ; 67(1): 119-25, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25514759

RESUMEN

Epidemiological studies show that heme iron from red meat is associated with increased colorectal cancer risk. In carcinogen-induced-rats, a heme iron-rich diet increases the number of precancerous lesions and raises associated fecal biomarkers. Heme-induced lipoperoxidation measured by fecal thiobarbituric acid reagents (TBARs) could explain the promotion of colon carcinogenesis by heme. Using a factorial design we studied if microbiota could be involved in heme-induced carcinogenesis, by modulating peroxidation. Rats treated or not with an antibiotic cocktail were given a control or a hemoglobin-diet. Fecal bacteria were counted on agar and TBARs concentration assayed in fecal water. The suppression of microbiota by antibiotics was associated with a reduction of crypt height and proliferation and with a cecum enlargement, which are characteristics of germ-free rats. Rats given hemoglobin diets had increased fecal TBARs, which were suppressed by the antibiotic treatment. A duplicate experiment in rats given dietary hemin yielded similar results. These data show that the intestinal microbiota is involved in enhancement of lipoperoxidation by heme iron. We thus suggest that microbiota could play a role in the heme-induced promotion of colorectal carcinogenesis.


Asunto(s)
Antibacterianos/uso terapéutico , Carcinogénesis/efectos de los fármacos , Colon/efectos de los fármacos , Neoplasias del Colon/prevención & control , Mucosa Intestinal/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Microbiota/efectos de los fármacos , Animales , Antibacterianos/efectos adversos , Anticarcinógenos/uso terapéutico , Biomarcadores/análisis , Ciego/efectos de los fármacos , Ciego/metabolismo , Ciego/microbiología , Ciego/patología , Proliferación Celular/efectos de los fármacos , Colon/metabolismo , Colon/microbiología , Colon/patología , Neoplasias del Colon/metabolismo , Neoplasias del Colon/microbiología , Neoplasias del Colon/patología , Recuento de Colonia Microbiana , Quimioterapia Combinada/efectos adversos , Heces/química , Heces/microbiología , Hemo/efectos adversos , Hemo/análisis , Hemo/antagonistas & inhibidores , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Distribución Aleatoria , Ratas Endogámicas F344 , Sustancias Reactivas al Ácido Tiobarbitúrico/análisis
3.
Rapid Commun Mass Spectrom ; 25(19): 2675-81, 2011 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-21913243

RESUMEN

4-Hydroxy-2(E)-nonenal (HNE), a product of lipid peroxidation, has been extensively studied in several areas, including metabolism with radio-isotopes and quantification in various matrices with deuterium-labelled HNE as standard. The aim of this work was to evaluate the relevance of (13)C-labelled HNE in biotransformation studies to discriminate metabolites from endogens by liquid chromatography/electrospray ionisation mass spectrometry (LC/ESI-MS). (13)C-Labelled HNE was synthesised in improved overall yield (20%), with the incorporation of two labels in the molecule. Immortalised mouse colon epithelial cells were incubated with 2:3 molar amounts of HNE/(13)C-HNE in order to gain information on the detection of metabolites in complex media. Our results demonstrated that the stable isotope m/z values determined by mass spectrometry were relevant in distinguishing metabolites from endogens, and that metabolite structures could be deduced. Six conjugate metabolites and 4-hydroxy-2(E)-nonenoic acid were identified, together with an incompletely identified metabolite. Stable-isotope-labelled HNE has already been used for quantification purposes. However, this is the first report on the use of (13)C-labelled HNE as a tracer for in vitro metabolism. (13)C-Labelled HNE could also be of benefit for in vivo studies.


Asunto(s)
Aldehídos/farmacocinética , Cromatografía Liquida/métodos , Colon/metabolismo , Espectrometría de Masa por Ionización de Electrospray/métodos , Aldehídos/química , Animales , Biotransformación , Isótopos de Carbono , Células Cultivadas , Colon/citología , Células Epiteliales/metabolismo , Femenino , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo , Marcaje Isotópico , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos
4.
Cancer Res ; 59(20): 5143-7, 1999 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-10537289

RESUMEN

Dietary polyethylene-glycol (PEG) 8000, a nonfermented polymer laxative, strongly suppresses azoxymethane-induced aberrant crypt foci (ACF) in the colon of rats, as shown in a previous study (D. E. Corpet et al., Carcinogenesis (Lond.), 20: 915-918, 1999). In the present study, we tested the effect of PEG administered during either initiation or postinitiation, the dose-response effect of PEG, the regressive effect of PEG on established ACF, and the preventive effect of PEG on colon cancers in rats. The general design was to initiate carcinogenesis in F344 rats by a single injection of azoxymethane (20 mg/kg) and to randomize the animals 7 days later to AIN-76 diets containing 5% PEG or no PEG (control). At termination, ACF and tumors were scored blindly by a single observer. The administration of 5% PEG for 32 days to groups of 10 female rats in either food or drinking water reduced the number of ACF by a factor of 8 (P = 0.0002) and reduced the number of large ACF by a factor of 20-30 (P = 0.002). No protection was afforded when PEG was given only during the initiation phase. Diets containing 0%, 0.5%, 2%, or 5% PEG fed for 35 days to four groups of male rats inhibited ACF in a dose-dependent manner (P < 0.0001). The administration of a 5% PEG diet for 41 days, starting 42 days after carcinogen injection, led to a 73% decrease in the number of ACF (P < 0.0001). Dietary PEG thus caused the regression of established ACF. Macroscopic tumors were evaluated by histology in rats that had been fed a high-fat diet containing cooked casein to promote tumor growth for 81 days. In this accelerated model of carcinogenesis, dietary PEG suppressed the occurrence of colon adenomas and carcinomas: the incidence of tumors decreased from 70% to 10% (P = 0.005); and the multiplicity decreased from 2.1 to 0.1 tumor(s)/rat (P = 0.003). No cancer was detected in the PEG-fed rats. Taken together, these results suggest that PEG could be a potent anticancer agent in the postinitiation phase of carcinogenesis. Because PEG is a substance that is generally recognized as safe (GRAS list, Food and Drug Administration), its cancer-preventive features could be tested in humans.


Asunto(s)
Neoplasias Colorrectales/tratamiento farmacológico , Polietilenglicoles/uso terapéutico , Lesiones Precancerosas/tratamiento farmacológico , Animales , Azoximetano/toxicidad , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Heces , Femenino , Masculino , Ratas , Ratas Endogámicas F344
5.
Cancer Res ; 60(12): 3160-4, 2000 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-10866305

RESUMEN

We have previously shown that dietary polyethylene-glycol (PEG) suppresses the occurrence of azoxymethane-induced cancers in an accelerated rat model of colon carcinogenesis. To determine the consistency of this preventive effect, we carried out a long-term study in rats fed the standard American Institute of Nutrition 1976 diet, and 7 short-term prevention studies in rodents. A total of 337 F344 rats, 20 Sprague Dawley rats, and 40 OF1 mice were all given initiating dose(s) of colon carcinogen, and were randomly allocated to experimental groups 7 d later. Treated groups received drinking water containing 5% PEG. After 30 or 162 d, the animals were examined for aberrant crypt foci or tumors in the colon. After two 20 mg/kg azoxymethane injections, the number of F344 rats with colon tumor was lower in rats receiving PEG for 162 d than in carcinogen-injected controls, 5/21 versus 25/27 (P < 0.0001). PEG-fed rats had no invasive cancer, and 10 times fewer colon tumors than controls (0.3+/-0.1 and 3.1+/-0.5 respectively, P < 0.0001). A three-day PEG treatment was sufficient to halve the number of azoxymethane-induced aberrant crypt foci in F344 rats (P = 0.0006). After 16 d of treatment, PEG-fed rats had five times fewer foci than controls (21+/-14 and 100+/-23 respectively, P < 0.0001), but the inhibition was reversible in part when treatment was discontinued. Aberrant crypt foci initiated by N-methyl-N-nitrosourea intra-rectally (40 mg/kg) or by 2-amino-3,4-dimethylimidazo(4,5-f)quinoline p.o. (2 x 200 mg/kg) were suppressed by PEG (P < 0.0001 and P = 0.003 respectively). PEG was active in F344 rats, in Sprague Dawley rats (P = 0.0005), and in OF1 mice (P = 0.001). PEGs with MW between 3350 and 12000 (but not PEG 400), and PEG 8000 from five suppliers, markedly inhibited azoxymethane-induced aberrant crypt foci (all P < 0.01). The prevention was stronger in rats fed a high-fat diet (P < 0.0001) than in rats fed a rodent chow (P = 0.02). PEG was thus a fast, consistent, and potent inhibitor of early colonic precursor lesions. Moreover, PEG is one of the most potent inhibitors of colon tumor in the standard rat model. Since PEG has no known toxicity in humans, we think it should be tested as a chemopreventive agent in a clinical trial.


Asunto(s)
Neoplasias del Colon/prevención & control , Polietilenglicoles/farmacología , Animales , Azoximetano , Carcinógenos , Neoplasias del Colon/inducido químicamente , Grasas de la Dieta/metabolismo , Relación Dosis-Respuesta a Droga , Femenino , Masculino , Metilnitrosourea , Ratones , Lesiones Precancerosas/tratamiento farmacológico , Quinolinas , Ratas , Ratas Endogámicas F344 , Ratas Sprague-Dawley , Factores de Tiempo
6.
Cancer Lett ; 114(1-2): 135-8, 1997 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-9103272

RESUMEN

Promotion would suppose the selection of initiated cells. We tested the selection of aberrant crypt cells by cholic acid, a colon cancer promoter, and the effect of protectors, phytate and food restriction. After an azoxymethane injection, rats were allocated to a control diet, or to supplements of cholic acid, sodium phytate, or to a 50% food restriction. The proliferation and apoptosis of 1200 crypts were assessed, after immuno-staining for BrdU. Cholic acid increased the proliferation of aberrant crypts but not of normal crypts. Phytate and food restriction decreased the proliferation of normal crypts, but not of aberrant crypts. Apoptosis was not affected by diets. Results support the hypothesis that cholic acid can select initiated cells in the colon.


Asunto(s)
Apoptosis/efectos de los fármacos , Ácidos Cólicos/farmacología , Neoplasias del Colon/patología , Mucosa Intestinal/patología , Ácido Fítico/farmacología , Lesiones Precancerosas/patología , Análisis de Varianza , Animales , Peso Corporal , División Celular/efectos de los fármacos , Ácido Cólico , Colon/efectos de los fármacos , Colon/patología , Enfermedades del Colon/inducido químicamente , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/prevención & control , Ingestión de Alimentos/fisiología , Femenino , Mucosa Intestinal/efectos de los fármacos , Lesiones Precancerosas/inducido químicamente , Ratas , Ratas Sprague-Dawley
7.
Cancer Lett ; 114(1-2): 35-8, 1997 Mar 19.
Artículo en Inglés | MEDLINE | ID: mdl-9103248

RESUMEN

Dietary fibers might lower the risk of colorectal cancer, maybe because of their bulking effect. We tested the protection afforded by an inert bulk against carcinogenesis. Thirty rats received an azoxymethane injection and were allocated to a control diet, or to a diet supplemented with 10% carborundum. After 100 days the colons were scored for aberrant crypt foci. Compared to controls, the fecal weight was doubled in carborundum-fed rats (P < 0.001), but the aberrant crypt foci multiplicity was not changed (P = 0.92). The results do not support the hypothesis that intestinal dilution by an inert bulk can protect against colon cancer.


Asunto(s)
Compuestos Inorgánicos de Carbono , Carbono/uso terapéutico , Neoplasias del Colon/prevención & control , Fibras de la Dieta/uso terapéutico , Lesiones Precancerosas/prevención & control , Compuestos de Silicona/uso terapéutico , Fosfatasa Alcalina/metabolismo , Animales , Ácidos y Sales Biliares/biosíntesis , Carbono/metabolismo , Neoplasias del Colon/inducido químicamente , Fibras de la Dieta/metabolismo , Heces/química , Femenino , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/patología , Ratas , Ratas Endogámicas F344 , Silicio , Compuestos de Silicona/metabolismo
8.
J Med Life ; 4(2): 163-7, 2011 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-21776299

RESUMEN

OBJECTIVE: The present study evaluated the effects on gestation, in terms of oxidative stress, of two antioxidant factors-vitamin E and coenzyme Q10-during pregnancy, with the purpose of applying the results in further human clinical practice. METHODS: For each aspect we have studied, we used three types of female rats of Wistar race (un-pregnant, primiparous, multiparous), divided in 10 rats/group. From the blood we have sampled, we have determined the oxidative stress (OS) markers: malondialdehyde (MDA) and carbonylated proteins (CP), but also the markers of the antioxidant defense: the hydrogen donor capacity of the plasma (HD) and the sulfhydryl groups (SH). RESULTS: Vitamin E administration determines significant decreases of MDA and significant increases of CP and HD at primiparous, and also significant increases of SH groups at multiparous. In the case of pregnant animals that received CoQ10 in antioxidant complexes, we have observed an increase of oxidative stress (OS)-MDA in primiparous and CP in multiparous. CONCLUSIONS: In the case of Vitamin E, taking into account the benefits on redox homeostasis, the decrease of OS, the authors recommend vitamin E administration during pregnancy. However, because of the increase of the OS in the case of pregnant animals, the authors do not recommend the administration of CoQ(10) in antioxidant complexes during pregnancy.


Asunto(s)
Antioxidantes/farmacología , Estrés Oxidativo/efectos de los fármacos , Ubiquinona/análogos & derivados , Vitamina E/farmacología , Animales , Femenino , Humanos , Hidrógeno/sangre , Malondialdehído/metabolismo , Embarazo , Carbonilación Proteica/efectos de los fármacos , Ratas , Ratas Wistar , Compuestos de Sulfhidrilo/metabolismo , Ubiquinona/administración & dosificación , Ubiquinona/farmacología , Vitamina E/administración & dosificación
10.
Glob Public Health ; 3(2): 137-48, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19288367

RESUMEN

The shortage of qualified health professionals is a major obstacle to achieving better health outcomes in many parts of the world, particularly in Africa. The role of health science universities in addressing this shortage is to provide quality education and continuing professional development opportunities for the healthcare workforce. Academic institutions in Africa, however, are also short of faculty and especially under-resourced. We describe the initial phase of an institutional partnership between the Muhimbili University of Health and Allied Sciences (MUHAS) and the University of California San Francisco (UCSF) centred on promoting medical education at MUHAS. The challenges facing the development of the partnership include the need: (1) for new funding mechanisms to provide long-term support for institutional partnerships, and (2) for institutional change at UCSF and MUHAS to recognize and support faculty activities that are important to the partnership. The growing interest in global health worldwide offers opportunities to explore new academic partnerships. It is important that their development and implementation be documented and evaluated as well as for lessons to be shared.


Asunto(s)
Conducta Cooperativa , Empleos en Salud/educación , Fuerza Laboral en Salud , Universidades , África , Educación Médica , Desarrollo de Programa , Evaluación de Programas y Proyectos de Salud , San Francisco
11.
Carcinogenesis ; 28(2): 321-7, 2007 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16885197

RESUMEN

Recent epidemiological studies suggest that high meat intake is associated with promotion of colon cancer linked with haem-iron intake. We previously reported that dietary haem, in the form of either haemoglobin or meat, promotes precancerous lesions in the colon of rats given a low-calcium diet. The mechanism of promotion by haem is not known, but is associated with increased lipid peroxidation in faecal water and strong cytotoxic activity of faecal water on a cancerous mouse colonic epithelial cell line. To better understand the involvement of faecal water components of haem-fed rats in colon-cancer promotion, we explored the effect of faecal water on normal [adenomatous polyposis coli (Apc)+/+] or premalignant cells (Apc-/+). Further, we tested if this effect was correlated to lipoperoxidation and 4-hydroxynonenal (HNE). We show here for the first time that heterozygote Apc mutation represents a strong selective advantage, via resistance to apoptosis induction (caspase 3 pathway), for colonic cells exposed to a haem-iron-induced lipoperoxidation. The fact that HNE treatment of the cells provoked the same effects as the faecal water of rats fed the haem-rich diet suggests that this compound triggers apoptosis in those cells. We propose that this mechanism could be involved in the promotion of colon carcinogenesis by haem in vivo.


Asunto(s)
Apoptosis/efectos de los fármacos , Agua Corporal , Colon/efectos de los fármacos , Heces , Genes APC , Hemo/administración & dosificación , Peróxidos Lipídicos/farmacología , Mutación , Animales , Colon/citología , Femenino , Ratas , Ratas Endogámicas F344
12.
J Food Prot ; 50(10): 862-866, 1987 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30978786

RESUMEN

After experimental contamination of bovine raw and heat-treated milks with bovine rotavirus and coronavirus strains, we observed a strong viral inhibition only with raw milks, from which virus recovery was 5 × 10-4%. Between 30% and 80% of the virus was recovered from the heat-treated milks, depending on the level of inoculation. The antiviral substance is heat-labile (destroyed within 30 min at 100°C), precipitated by ammonium sulfate and filtrable (0.45 µm Millipore membrane). It also has neutralizing activity on tissue culture.

13.
Br J Cancer ; 84(1): 90-3, 2001 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-11139319

RESUMEN

Polyethylene-glycol (PEG) is a strong inhibitor of colon cancer in rats, and the most potent suppressor of aberrant crypt foci. 9 PEG-like block copolymers were tested in rodents, after an azoxymethane injection. Dietary pluronic F68 led to a 98.6% reduction in the number of aberrant crypt foci in a first rat study (P< 0.0001). Next 3 studies confirmed this pluronic efficacy in rats and mice. This non-toxic laxative seems roughly 5 times more potent than PEG for chemoprevention.


Asunto(s)
Colon/efectos de los fármacos , Neoplasias del Colon/prevención & control , Excipientes/farmacología , Poloxámero/farmacología , Polietilenglicoles/farmacología , Lesiones Precancerosas/prevención & control , Animales , Ensayos de Selección de Medicamentos Antitumorales , Femenino , Masculino , Ratones , Ratas , Ratas Endogámicas F344
14.
Nutr Cancer ; 27(3): 316-20, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9101563

RESUMEN

The main objective of the present study was to test the hypothesis that exogenous insulin would enhance colon carcinogenesis. Thirty-six female Fischer 344 rats were fed ad libitum a low-fat rodent chow and given a single azoxymethane injection (20 mg/kg); one week later, they were randomized into two groups. Control rats were given a subcutaneous saline injection, 5 days/wk, and experimental rats were given Ultralente bovine insulin (20 U/kg). The promoting effect of insulin injections was assessed by the multiplicity (number of crypts) of aberrant crypt foci after 100 days of treatment (72 injections). The rats given insulin ate more and were heavier than controls (215 +/- 11 vs. 182 +/- 7 g, p < 0.001). Insulin injections also increased the amount of abdominal fat, plasma triglycerides, and insulinemia and decreased blood glucose (all p < 0.05). The number of aberrant crypt foci was the same in both groups, but their multiplicity was significantly increased by the insulin injections (2.8 +/- 0.3 vs. 2.5 +/- 0.2 crypt/focus in controls, p = 0.007). In addition, the proportion of sialomucin-producing foci was higher in insulin-injected rats than in controls (p = 0.04). These data show that exogenous insulin can promote colon carcinogenesis in rats and suggest that life-style and diets leading to low blood insulin might protect humans against colorectal cancer.


Asunto(s)
Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/patología , Insulina/efectos adversos , Animales , Azoximetano , Composición Corporal/efectos de los fármacos , Carcinógenos , Colon/metabolismo , Colon/patología , Ingestión de Alimentos/efectos de los fármacos , Femenino , Insulina/administración & dosificación , Insulina/sangre , Mucinas/metabolismo , Ratas , Ratas Endogámicas F344 , Sialomucinas , Aumento de Peso/efectos de los fármacos
15.
Nutr Cancer ; 32(1): 29-36, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9824854

RESUMEN

We speculated that a diet with a high glycemic index (GI) or a diet with a low nutrient density (nutrient-to-calorie ratio) would enhance colon carcinogenesis, presumably via increased insulin resistance. Forty-eight Sprague-Dawley (SD) rats received an azoxymethane injection (20 mg/kg) and were randomized into five groups given an AIN-76 diet containing 1) 65% starch by weight, 2) 65% glucose (GI = 100), 3) 65% fructose (GI = 23), 4) 82% starch, or 5) 39% oil and 39% sucrose. The nutrient density of Diets 4 and 5 was one-half that of Diets 1-3. Promotion was assessed by the multiplicity (number of crypts) of aberrant crypt foci (ACF), an early marker of colon carcinogenesis. Insulin resistance was estimated by the FIRI index (blood insulin x blood glucose), by plasma triglycerides, and by visceral fat. To confirm the results in another rat strain, the experiment was duplicated in 48 Fischer (F344) rats. Results show that 1) the ACF multiplicity was not different in glucose- and fructose-fed rats (p > 0.7): diets with contrasting GI had the same effect on ACF growth; 2) diets of low nutrient density increased visceral fat (p < 0.05) but reduced the ACF size in F344 rats (p < 0.001, no reduction in SD rats); and 3) indirect insulin resistance markers (FIRI index, blood triglycerides, and visceral fat) did not correlate with ACF multiplicity. These results do not support the hypothesis that diets with a high GI or low nutrient density or diets that increase some indirect insulin resistance markers can promote colon carcinogenesis in F344 or SD rats.


Asunto(s)
Neoplasias del Colon/metabolismo , Sacarosa en la Dieta/efectos adversos , Glucosa/metabolismo , Estado Nutricional , Lesiones Precancerosas/metabolismo , Tejido Adiposo/fisiología , Animales , Peso Corporal/fisiología , Ingestión de Alimentos/fisiología , Ingestión de Energía , Heces/química , Femenino , Ratas , Ratas Sprague-Dawley , Factores de Riesgo , Vísceras/fisiología
16.
Nutr Cancer ; 32(3): 165-73, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-10050267

RESUMEN

High intake of red meat or processed meat is associated with increased risk of colon cancer. In contrast, consumption of white meat (chicken) is not associated with risk and might even reduce the occurrence of colorectal cancer. We speculated that a diet containing beef or bacon would increase and a diet containing chicken would decrease colon carcinogenesis in rats. One hundred female Fischer 344 rats were given a single injection of azoxymethane (20 mg/kg i.p.), then randomized to 10 different AIN-76-based diets. Five diets were adjusted to 14% fat and 23% protein and five other diets to 28% fat and 40% protein. Fat and protein were supplied by 1) lard and casein, 2) olive oil and casein, 3) beef, 4) chicken with skin, and 5) bacon. Meat diets contained 30% or 60% freeze-dried fried meat. The diets were given ad libitum for 100 days, then colon tumor promotion was assessed by the multiplicity of aberrant crypt foci [number of crypts per aberrant crypt focus (ACF)]. The ACF multiplicity was nearly the same in all groups, except bacon-fed rats, with no effect of fat and protein level or source (p = 0.7 between 8 groups by analysis of variance). In contrast, compared with lard- and casein-fed controls, the ACF multiplicity was reduced by 12% in rats fed a diet with 30% bacon and by 20% in rats fed a diet with 60% bacon (p < 0.001). The water intake was higher in bacon-fed rats than in controls (p < 0.0001). The concentrations of iron and bile acids in fecal water and total fatty acids in feces changed with diet, but there was no correlation between these concentrations and the ACF multiplicity. Thus the hypothesis that colonic iron, bile acids, or total fatty acids can promote colon tumors is not supported by this study. The results suggest that, in rats, beef does not promote the growth of ACF and chicken does not protect against colon carcinogenesis. A bacon-based diet appears to protect against carcinogenesis, perhaps because bacon contains 5% NaCl and increased the rats' water intake.


Asunto(s)
Neoplasias del Colon/etiología , Dieta , Carne/efectos adversos , Tejido Adiposo/anatomía & histología , Animales , Azoximetano , Ácidos y Sales Biliares/análisis , Carcinógenos , Bovinos , Pollos , Colon/anatomía & histología , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/prevención & control , Ingestión de Líquidos , Ingestión de Alimentos , Ácidos Grasos/análisis , Heces/química , Femenino , Hierro/análisis , Distribución Aleatoria , Ratas , Ratas Endogámicas F344 , Factores de Riesgo , Porcinos , Vísceras , Aumento de Peso
17.
Nutr Cancer ; 38(1): 74-80, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11341048

RESUMEN

Processed meat intake is associated with increased risk of colorectal cancer. This association may be explained by the endogenous formation of N-nitroso compounds (NOC). The hypothesis that meat intake can increase fecal NOC levels and colon carcinogenesis was tested in 175 Fischer 344 rats. Initiation was assessed by the number of aberrant crypt foci (ACF) in the colon of rats 45 days after the start of a high-fat bacon-based diet. Promotion was assessed by the multiplicity of ACF (crypts per ACF) in rats given experimental diets for 100 days starting 7 days after an azoxymethane injection. Three promotion studies were done, each in 5 groups of 10 rats, whose diets contained 7%, 14%, or 28% fat. Tested meats were bacon, pork, chicken, and beef. Fecal and dietary NOC were assayed by thermal energy analysis. Results show that feces from rats fed bacon-based diets contained 10-20 times more NOC than feces from control rats fed a casein-based diet (all p < 0.0001 in 4 studies). In bacon-fed rats, the amount of NOC input (diet) and output (feces) was similar. Rats fed a diet based on beef, pork, or chicken meat had less fecal NOC than controls (most p < 0.01). No ACF were detected in the colon of bacon-fed uninitiated rats. After azoxymethane injection, unprocessed but cooked meat-based diets did not change the number of ACF or the ACF multiplicity compared with control rats. In contrast, the bacon-based diet consistently reduced the number of large ACF per rat and the ACF multiplicity in the three promotion studies by 12%, 17%, and 20% (all p < 0.01). Results suggest that NOC from dietary bacon would not enhance colon carcinogenesis in rats.


Asunto(s)
Neoplasias del Colon/etiología , Carne/efectos adversos , Compuestos Nitrosos/efectos adversos , Animales , Azoximetano/toxicidad , Carcinógenos , Bovinos , Pollos , Neoplasias del Colon/inducido químicamente , Neoplasias del Colon/prevención & control , Grasas de la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Heces/química , Femenino , Manipulación de Alimentos , Carne/análisis , Compuestos Nitrosos/análisis , Distribución Aleatoria , Ratas , Ratas Endogámicas F344 , Factores de Riesgo , Porcinos
18.
Nutr Cancer ; 37(2): 193-8, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11142093

RESUMEN

Carrageenans (CAR) are sulfated polymers from seaweed used as gelling agents in foods. Chemical carcinogen induction of tumors in the colon of rats is enhanced by CAR. We speculated that gut microflora is involved in this effect. We thus studied the initiating and promoting effects of undegraded CAR-kappa (345,000 mol wt) in conventional rats and in germ-free rats associated with a human fecal flora. The initiating effect of CAR was studied by scoring aberrant crypt foci (ACF) in the colon of Fischer 344 rats given CAR (10% in water). The promoting effect of CAR was studied by comparing the multiplicity of ACF (number of crypts/focus) in rats receiving pure water or CAR (0.25% and 2.5% in water) for 100 days, starting 7 days after azoxymethane initiation (1 dose of 20 mg/kg i.p.). Duplicate studies were conducted in conventional rats and in human flora-associated rats maintained in isolators. Results show that CAR did not initiate ACF. In conventional rats, the 2.5% CAR gel promoted the growth of ACF: 2.98 +/- 0.29 and 3.44 +/- 0.48 crypts/ACF in control and treated rats, respectively (p < 0.02). The 0.25% CAR gel did not promote ACF. CAR can thus enhance intestinal tumors in this rat model, but only at a high dose level. In contrast, we did not observe any promoting effect of the administration of the 2.5% CAR gel in human flora-associated rats: 2.81 +/- 0.18 and 2.78 +/- 0.38 crypts/ACF in control and treated rats, respectively (p = 0.80). The specific microflora of rats, but not the human gut flora, might be involved in colon tumor enhancement by CAR.


Asunto(s)
Carragenina/farmacología , Colon/efectos de los fármacos , Neoplasias del Colon/inducido químicamente , Lesiones Precancerosas/inducido químicamente , Animales , Azoximetano , Carcinógenos , Carragenina/administración & dosificación , Carragenina/química , Carragenina/aislamiento & purificación , Colon/microbiología , Colon/patología , Neoplasias del Colon/microbiología , Neoplasias del Colon/prevención & control , Relación Dosis-Respuesta a Droga , Heces/química , Femenino , Geles , Vida Libre de Gérmenes , Peso Molecular , Lesiones Precancerosas/microbiología , Ratas , Ratas Endogámicas F344
19.
Br J Clin Pharmacol ; 54(4): 433-6, 2002 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12392593

RESUMEN

AIMS: To investigate how risk of adverse drug reactions (ADRs) of several drug classes is perceived by health vs non health professionals. METHODS: Four hundred health professionals (i.e. 278 general practitioners, 76 pharmacists and 46 pharmacovigilance professionals) and 153 non health professionals were interviewed. Visual analogue scales were used to define a score of perceived risk of ADRs associated with each drug class (ranking from 0 to 10). RESULTS: Anticoagulants were ranked as the most dangerous drugs by general practitioners [median score (25th-75th centiles): 7.9 (6.7-9.0)], pharmacists [8.7 (7.8-9.7)] and pharmacovigilance professionals [8.1 (7.2-9.0)]. For non health professionals, the class ranked first was sleeping pills [8.7 (7.2-9.4)] followed by tranquillisers [8.2 (6.4-9.2)] and antidepressants [8.0 (5.9-9.1)]. Aspirin was listed in the last position by non health professionals [3.4 (1.5-5.4)]. CONCLUSIONS: There are major differences in the perception of risk of ADRs between health professionals and non health professionals.


Asunto(s)
Actitud del Personal de Salud , Actitud Frente a la Salud , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Adulto , Medicina Familiar y Comunitaria , Francia , Humanos , Persona de Mediana Edad , Percepción , Farmacología , Práctica Profesional , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA